Cite

HARVARD Citation

    Khan, N. et al. (2022). Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients. Inflammatory bowel diseases. 28 (5), pp. 734-744. [Online]. 
  
Back to record